SEARCH

SEARCH BY CITATION

REFERENCES

  • Cleghorn, F.R., Manns, A., Falk, R., Hartge, P., Hanchard, B., Jack, N., Williams, E., Jaffe, E., White, F., Bartholomew, C. and Blattner, W.A., Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence. J. nat. Cancer Inst., 87, 1009-1014 (1995).
  • Gerard, Y. and 15 others, Clustering and clinical diversity of adult T-cell leukemia/lymphoma associated with HTLV-I in a remote black population of French Guiana. Int. J. Cancer, 60, 773-776 (1995).
  • Hino, S., Katamine, S., Miyata, H., Tsuji, Y., Yamabe, T. and Miyamoto, T., Primary prevention of HTLV-I in Japan. J. AIDS hum. Retrovirol., 13 (Suppl. 1), S199S203 (1996).
  • Hisada, M., Okayama, A., Tachibana, N., Stuver, S.O., Spiegelman, D.L., Tsubouchi, H. and Mueller, N.E., Predictors of level of circulating abnormal lymphocytes among human T-lymphotropic virus type I carriers in Japan. Int. J. Cancer, 77, 188-192 (1998).
  • IARC, Human T-cell lymphotropic viruses. In: Human immunodeficiency viruses and human T-cell lymphotropic viruses, IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 67, pp. 261-390, IARC, Lyon (1996).
  • Ikeda, S., Momita, S., Kinoshita, K., Kamihira, S., Moriuchi, Y., Tsukasaki, K., Ito, M., Kanda, T., Moriuchi, R., Nakamura, T. and Tomonaga, M., Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: defining a low- and high-risk population. Blood, 82, 2017-2024 (1993).
  • Iwata, K., Ito, S., Saito, H., Ito, M., Nagatomo, M., Yamasaki, T., Yoshida, S., Suto, H. and Tajima, K., Mortality among inhabitants of an HTLV-I endemic area in Japan. Jap. J. Cancer Res., 85, 231-237 (1994).
  • Kamihira, S., Yamada, Y., Ikeda, S., Momita, S., Atogami, S., Sohda, H., Tomonaga, M. and Tokudome, S., Risk of adult T-cell leukemia developing in individuals with HTLV-I infection. Leukemia Lymphoma, 6, 437-439 (1992).
  • Kondo, T. and 15 others, Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int. J. Cancer, 43, 1061-1064 (1989).
  • LaGrenade, L., Hanchard, B., Fletcher, V., Cranston, B. and Blattner, W., Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet, 336, 1345-1347 (1990).
  • Levine, P.H. and 14 others, Adult T-cell leukemia/lymphoma: a working point score classification for epidemiological studies. Int. J. Cancer, 59, 491-493 (1994a).
  • Levine, P.H., Manns, A., Jaffe, E.S., Colclough, G., Cavallaro, A., Reddy, G. and Blattner, W.A., The effect of ethnic differences on the pattern of HTLV-I-associated T-cell leukemia/lymphoma (HATL) in the United States. Int. J. Cancer, 56, 177-181 (1994b).
  • Morofuji-Hirata, M., Kajiyama, W., Nakashima, K., Noguchi, A., Hayashi, J. and Kashiwagi, S., Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years. Amer. J. Epidemiol., 137, 43-48 (1993).
  • Murphy, E.L., Hanchard, B., Figueroa, J.P., Gibbs, W.N., Lofters, W.S., Campbell, M., Goedert, J.J. and Blattner, W.A., Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type-I. Int. J. Cancer, 43, 250-253 (1989).
  • Oguma, S., Imamura, Y., Kusumoto, Y., Nishimura, Y., Yamaguchi, K., Takatsuki, K., Tokudome, S. and Okuma, M., Accelerated declining tendency of human T-cell leukemia virus type I carrier rates among younger blood donors in Kumamoto, Japan. Cancer Res., 52, 2620-2623 (1992).
  • Plancoulaine, S., Buigues, R.P., Murphy, E.L., van Beveren, M., Pouliquen, J.F., Joubert, M., Remy, F., Tuppin, P., Tortevoye, P., de Thé, G., Moreau, J.P. and Gessain, A., Demographic and familial characteristics of HTLV-I infection among an isolated, highly endemic population of African origin in French Guiana. Int. J. Cancer, 76, 331-336 (1998).
  • Plummer, M., Age standardization. In: D.M.Parkin, S.L.Whelan, J.Ferlay, L.Raymond and J.Young (eds.), Cancer incidence in five continents, Vol. VII, pp. 66-68, IARC Scientific Publications, IARC, Lyon (1997).
  • Soda, M. and Ikeda, T., Japan, Nagasaki Prefecture. In: D.M.Parkin, S.L.Whelan, J.Ferlay, L.Raymond and J.Young (eds.), Cancer incidence in five continents, Vol. VII, pp. 390-393, IARC Scientific Publications, IARC, Lyon (1997).
  • Statistics Bureau, Management and Coordination Agency, 1990 Population Census of Japan. Vol. 2. Results of the first basic complete tabulation, Part 2. 42 Nagasaki Prefecture, pp. 8-77, Japanese Statistics Association, Tokyo (1990).
  • Stuver, S.O., Tachibana, N., Okayama, A., Shioiri, S., Tsunetoshi, Y., Tsuda, K. and Mueller, N.E., Heterosexual transmission of human T-cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J. infect. Dis., 167, 57-65 (1993).
  • Tajima, K., Kamura, S., Ito, S., Ito, M., Nagatomo, M., Kinoshita, K. and Ikeda, S., Epidemiological features of HTLV-I carriers and incidence of ATL in an ATL-endemic island: a report of the community-based co-operative study in Tsushima, Japan. Int. J. Cancer, 40, 741-746 (1987).
  • Takezaki, T., Hirose, K., Hamajima, N., Kuroishi, T. and Tajima, K., Estimation of adult T-cell leukemia incidence in Kyushu district from vital statistics Japan between 1983 and 1992: comparison with a nationwide survey. Jap. J. clin. Oncol., 27, 140-145 (1997).
  • T- and B-Cell Malignancy Study Group, A report from the 7th nationwide study of adult T-cell leukemia/lymphoma in Japan. Jap. J. Cancer Clin., 42, 231-247 (1996).
  • Tokudome, S., Tokunaga, O., Shimamoto, Y., Miyamoto, Y., Sumida, I., Kikuchi, M., Takeshita, M., Ikeda, T., Fujiwara, K., Yoshihara, M., Yanagawa, T. and Nishizumi, M., Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type I carriers in Saga, Japan. Cancer Res., 49, 226-228 (1989).
  • Tokudome, S. and 13 others, Smoking and adult T-cell leukemia/lymphoma. Europ. J. Cancer Prev., 2, 84-85 (1993).
  • Yamaguchi, K., Seiki, M., Yoshida, M., Nishimura, H., Kawano, F. and Takatsuki, K., The detection of human T cell leukemia virus proviral DNA and its application for classification and diagnosis of T cell malignancy. Blood, 63, 1235-1240 (1984).